164 related articles for article (PubMed ID: 26480284)
1. Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma.
Klein Hesselink EN; Lefrandt JD; Schuurmans EP; Burgerhof JG; Groen B; Gansevoort RT; van der Horst-Schrivers AN; Dullaart RP; Van Gelder IC; Brouwers AH; Rienstra M; Links TP
J Clin Endocrinol Metab; 2015 Dec; 100(12):4563-9. PubMed ID: 26480284
[TBL] [Abstract][Full Text] [Related]
2. Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study.
Klein Hesselink EN; Klein Hesselink MS; de Bock GH; Gansevoort RT; Bakker SJ; Vredeveld EJ; van der Horst-Schrivers AN; van der Horst IC; Kamphuisen PW; Plukker JT; Links TP; Lefrandt JD
J Clin Oncol; 2013 Nov; 31(32):4046-53. PubMed ID: 24101052
[TBL] [Abstract][Full Text] [Related]
3. Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer.
Pajamäki N; Metso S; Hakala T; Ebeling T; Huhtala H; Ryödi E; Sand J; Jukkola-Vuorinen A; Kellokumpu-Lehtinen PL; Jaatinen P
Clin Endocrinol (Oxf); 2018 Feb; 88(2):303-310. PubMed ID: 29154445
[TBL] [Abstract][Full Text] [Related]
4. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
5. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
[TBL] [Abstract][Full Text] [Related]
6. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
7. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
8. Risk of incident circulatory disease in patients treated for differentiated thyroid carcinoma with no history of cardiovascular disease.
Toulis KA; Viola D; Gkoutos G; Keerthy D; Boelaert K; Nirantharakumar K
Clin Endocrinol (Oxf); 2019 Aug; 91(2):323-330. PubMed ID: 30993728
[TBL] [Abstract][Full Text] [Related]
9. Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis.
Kostopoulos G; Doundoulakis I; Antza C; Bouras E; Nirantharakumar K; Tsiachris D; Thomas GN; Lip GYH; Toulis KA
Endocr Relat Cancer; 2021 Apr; 28(5):325-335. PubMed ID: 33794503
[TBL] [Abstract][Full Text] [Related]
10. The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative (131)I dose over 37 GBq.
Khang AR; Cho SW; Choi HS; Ahn HY; Yoo WS; Kim KW; Kang KW; Yi KH; Park DJ; Lee DS; Chung JK; Cho BY; Park YJ
Clin Endocrinol (Oxf); 2015 Jul; 83(1):117-23. PubMed ID: 25115234
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Nonthyroidal Primary Malignancy and the Association with (131)I Treatment in Patients with Differentiated Thyroid Cancer.
Hirsch D; Shohat T; Gorshtein A; Robenshtok E; Shimon I; Benbassat C
Thyroid; 2016 Aug; 26(8):1110-6. PubMed ID: 27302111
[TBL] [Abstract][Full Text] [Related]
12. Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series.
Perticone F; Pigliaru F; Mariotti S; Deiana L; Furlani L; Mortini P; Losa M
Thyroid; 2015 Apr; 25(4):417-24. PubMed ID: 25647054
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.
Wang CC; Lin CL; Wang GJ; Chang CT; Sung FC; Kao CH
Thromb Haemost; 2015 Jan; 113(1):185-92. PubMed ID: 25318828
[TBL] [Abstract][Full Text] [Related]
14. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
Potpara TS; Polovina MM; Marinkovic JM; Lip GY
Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of distant metastasis from differentiated thyroid carcinoma.
Huang IC; Chou FF; Liu RT; Tung SC; Chen JF; Kuo MC; Hsieh CJ; Wang PW
Clin Endocrinol (Oxf); 2012 Mar; 76(3):439-47. PubMed ID: 21950769
[TBL] [Abstract][Full Text] [Related]
16. Spinal cord injury is associated with an increased risk of atrial fibrillation: A population-based cohort study.
Wang CC; Chang CT; Lin CL; Huang BR; Kao CH
Heart Rhythm; 2016 Feb; 13(2):416-23. PubMed ID: 26477711
[TBL] [Abstract][Full Text] [Related]
17. New-onset atrial fibrillation predicts long-term newly developed atrial fibrillation after coronary artery bypass graft.
Lee SH; Kang DR; Uhm JS; Shim J; Sung JH; Kim JY; Pak HN; Lee MH; Joung B
Am Heart J; 2014 Apr; 167(4):593-600.e1. PubMed ID: 24655710
[TBL] [Abstract][Full Text] [Related]
18. Implications of new-onset atrial fibrillation after cardiac surgery on long-term prognosis: a community-based study.
Melduni RM; Schaff HV; Bailey KR; Cha SS; Ammash NM; Seward JB; Gersh BJ
Am Heart J; 2015 Oct; 170(4):659-68. PubMed ID: 26386789
[TBL] [Abstract][Full Text] [Related]
19. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma.
Wang LY; Smith AW; Palmer FL; Tuttle RM; Mahrous A; Nixon IJ; Patel SG; Ganly I; Fagin JA; Boucai L
Thyroid; 2015 Mar; 25(3):300-7. PubMed ID: 25386760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
